Lena Mårtensson Wernrud
Direktor/Vorstandsmitglied bei Oncorena AB
Aktive Positionen von Lena Mårtensson Wernrud
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Lena Mårtensson Wernrud
Ehemalige bekannte Positionen von Lena Mårtensson Wernrud
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Direktor/Vorstandsmitglied | - | - |
| University of Lund | Corporate Officer/Principal | 01.01.1992 | - |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | - | - |
| GENOVIS AB | Direktor/Vorstandsmitglied | 01.01.2014 | - |
| Independent Dir/Board Member | 01.01.2014 | - |
Ausbildung von Lena Mårtensson Wernrud
| University of Lund | Doctorate Degree |
| The University of Colorado School of Medicine | Graduate Degree |
| University of Southern Denmark | Graduate Degree |
Statistik
International
| Schweden | 5 |
| Dänemark | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 3 |
| Graduate Degree | 2 |
| Corporate Officer/Principal | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENOVIS AB | Health Technology |
| Private Unternehmen | 3 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
- Börse
- Insiders
- Lena Mårtensson Wernrud
- Erfahrung
